MD Anderson, through its Shared Governance Committee, is moving away from an “autocratic” structure, said Julie Izzo, chair of the Faculty Senate and an associate professor in Translational Molecular Pathology at MD Anderson Cancer Center.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
